OCUPHIRE PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.735 USD | +0.29% |
|
-11.48% | -42.36% |
| May. 10 | Ocuphire Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 11 | Ocuphire Pharma Enrolls 1st Patient in Phase 3 Trial of Visual Acuity Treatment | MT |
cd3a038edb6.qko4X3MWL7IBbbFaaMH3Jlmb1F-I2G8yfaNZo930sM0.knxyJhF9XcRiKtwxEbC2ZRKq4TjjnDl5Cfkg2Zqu4qbjfH5sGVNrwmMU8A~a9fd262ab40eef0c83925e62112811f0